Private company

Morphic Holding, Inc.

We are a biopharmaceutical company applying our proprietary insights into integrins to discover and develop a pipeline of potentially first-in-class oral small molecule integrin therapeutics.4 From its latest annual report

Last updated Oct 19, 2026.

Overview

  • IndustryPharmaceutical Preparations2
  • HeadquartersWaltham, United States2
  • Incorporated inDE3
  • Business address35 Gatehouse Drive A2, Waltham, Ma 024513
  • Filer categoryLarge accelerated filer3
  • Legal formCorporation2
  • LEI549300RWWOUFLHTY12242
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressC/O THE CORPORATION TRUST COMPANY, 19801 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 55902142

See how the biggest companies compare on our leaderboards

We are a biopharmaceutical company applying our proprietary insights into integrins to discover and develop a pipeline of potentially first-in-class oral small molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular and metabolic diseases, fibrosis and cancer. To date, no oral small molecule integrin therapies have been approved by the U.S. Food and Drug Administration, or FDA. Despite this, we believe our unique platform can unlock the potential to reliably generate high-quality oral molecules against specific integrin targets. The Morphic integrin technology platform, or MInT Platform, was created leveraging our unique understanding of integrin structure and function to develop novel product candidates designed to achieve the potency, high selecti…4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

-34296.7%Operating margin5
-29192.9%Net margin5
-99.3%Revenue growth, 20235
-21.8%Return on equity5
-$113.6MFree cash flow5

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Research and development100¢$140.4M
  • Income tax0¢$380.0K

Out of $521.0K in revenue.5 The company lost money this year.

Financial statements

Revenue6785$521.0K in 2023−84% since 2018
0$20.0M$40.0M$60.0M$80.0M2018: $3.4M$3.4M20182019: $17.0M$17.0M2019+406%2020: $44.9M$44.9M2020+165%2021: $19.8M$19.8M2021−56%2022: $70.8M$70.8M2022+258%2023: $521.0K$521.0K2023−99%
Operating income6785-$178.7M in 2023+626% since 2018
-$200.0M-$150.0M-$100.0M-$50.0M02018: -$24.6M-$24.6M20182019: -$47.0M-$47.0M2019+91%2020: -$47.2M-$47.2M2020+0%2021: -$95.8M-$95.8M2021+103%2022: -$63.4M-$63.4M2022−34%2023: -$178.7M-$178.7M2023+182%
Net income6785-$152.1M in 2023+538% since 2018
-$200.0M-$150.0M-$100.0M-$50.0M02018: -$23.8M-$23.8M20182019: -$43.3M-$43.3M2019+82%2020: -$45.0M-$45.0M2020+4%2021: -$95.5M-$95.5M2021+112%2022: -$59.0M-$59.0M2022−38%2023: -$152.1M-$152.1M2023+158%
Fiscal year2017201820192020202120222023
Revenue$3.4M6$17.0M7$44.9M8$19.8M5$70.8M5$521.0K5
Research and development$22.6M6$53.7M7$73.6M8$87.8M5$102.1M5$140.4M5
Operating expenses$115.6M5$134.2M5$179.2M5
Operating income-$24.6M6-$47.0M7-$47.2M8-$95.8M5-$63.4M5-$178.7M5
Interest$43.0K6
Income before tax-$95.5M5-$59.0M5-$151.7M5
Income tax$06$912.0K7-$570.0K8$05$67.0K5$380.0K5
Net income-$23.8M6-$43.3M7-$45.0M8-$95.5M5-$59.0M5-$152.1M5
Earnings per share-$2.697-$1.478-$2.675-$1.555-$3.595
Earnings per share (diluted)-$2.697-$1.478-$2.675-$1.555-$3.595
Shares (weighted, basic)35.8M shares538.1M shares542.4M shares5
Shares (weighted, diluted)35.8M shares538.1M shares542.4M shares5

Compare Morphic Holding, Inc. with another company

Leadership

Who has led Morphic Holding, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Praveen P. Tipirneni2019–2024

President

  1. Praveen P. Tipirneni2019–2024

Chief financial officer

  1. Marc Schegerin2020–2024

Chief operating officer

  1. Marc Schegerin2020–2024
20202025
Board members and other officers (17)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive OfficerBruce E. Rogers named Mar 1, 202330
  • Executive OfficerRobert E. Farrell named Mar 1, 202330

Former names

  • Morphic Holding, LLCJul 13, 2016 to Oct 1, 20183

Timeline

  1. Jun 26, 2019New chief executive Praveen P. Tipirneni becomes CEO12

Filings

220 filings to the SEC since October 2021: 3 annual reports, 9 quarterly reports, 31 major events, 108 insider forms, 24 large holders, 1 private raises, 44 other. The latest 20:

  1. Nov 14, 2024SC 13G/A MORPHIC HOLDING, INC. EDGAR
  2. Aug 26, 202415-12G EDGAR
  3. Aug 21, 20244 EDGAR
  4. Aug 20, 20244 EDGAR
  5. Aug 20, 20244 EDGAR
  6. Aug 20, 20244 EDGAR
  7. Aug 20, 20244 EDGAR
  8. Aug 20, 20244 EDGAR
  9. Aug 20, 20244 EDGAR
  10. Aug 20, 20244 EDGAR
  11. Aug 20, 20244 EDGAR
  12. Aug 20, 20244 EDGAR
  13. Aug 20, 20244 EDGAR
  14. Aug 20, 20244 EDGAR
  15. Aug 20, 20244 EDGAR
  16. Aug 16, 2024S-8 POS EDGAR
  17. Aug 16, 2024S-8 POS EDGAR
  18. Aug 16, 2024S-8 POS EDGAR
  19. Aug 16, 2024S-8 POS EDGAR
  20. Aug 16, 2024S-8 POS EDGAR

The 220 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

43 open-market trades by officers, directors and large owners since October 2021: 3 buys and 40 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jul 8, 2024Rogers BrucePRESIDENTSale20,000$55.79$1.1MForm 4
Jul 8, 2024SCHEGERIN MARCCFO and COOSale43,936$55.80$2.5MForm 4
Jul 8, 2024Tipirneni Praveen P.President and CEOSale21,582$55.79$1.2MForm 4
Jul 8, 2024Farrell Robert E JrSVP Finance and CAOSale30,272$55.80$1.7MForm 4
Jul 8, 2024DeVaul WilliamGeneral Counsel and SecretarySale10,000$55.79$557.9KForm 4
Jan 16, 2024Tipirneni Praveen P.President and CEOSale13,923$27.49$382.7KForm 4
Jan 16, 2024SCHEGERIN MARCCFO and COOSale6,041$27.49$166.1KForm 4
Jan 16, 2024Rogers BrucePRESIDENTSale6,314$27.49$173.6KForm 4
Jan 16, 2024Farrell Robert E JrSVP Finance and CAOSale5,089$27.49$139.9KForm 4
Jan 16, 2024DeVaul WilliamGeneral Counsel and SecretarySale4,509$27.49$124.0KForm 4
Nov 13, 2023Edwards MartinDirectorBuy2,376$20.54$48.8KForm 4
Nov 13, 2023SLATTERY JOSEPH PDirectorBuy2,400$20.60$49.4KForm 4
Sep 7, 2023SCHEGERIN MARCCFO and COOSale20,000$54.34$1.1MForm 4
Aug 1, 2023Tipirneni Praveen P.President and CEOSale3,597$57.04$205.2KForm 4
Jul 3, 2023Tipirneni Praveen P.President and CEOSale3,597$57.04$205.2KForm 4
Jun 12, 2023Tipirneni Praveen P.President and CEOSale840$63.01$52.9KForm 4
Jun 7, 2023DeVaul WilliamGeneral Counsel and SecretarySale7,756$60.05$465.7KForm 4
Jun 1, 2023Tipirneni Praveen P.President and CEOSale3,597$57.14$205.5KForm 4
May 24, 2023DeVaul WilliamGeneral Counsel and SecretarySale100$60.00$6.0KForm 4
May 23, 2023Farrell Robert E JrSVP Finance and CAOSale10,000$60.00$600.0KForm 4

All 43 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Feb 15, 2023Raised $100 million in a private offering of equity Form D: $100 million offered in all Form D

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40